Abstract
Many cytokines exert their effect via the JAK/STAT signal transduction pathway. Due to the medical relevance of many of these cytokines, they are being exploited, either directly, or through antagonists, as therapeutics for a variety of serious diseases. Currently, these therapeutics consist almost entirely of protein products, with all of their attendant drawbacks. Delineation of the signaling mechanisms for the cytokines, however, has allowed the design and implementation of a variety of cell-based and biochemical screens for small molecule mimics or antagonists of these cytokines. Several successful assays will be described along with the advantages of each type of assay. Use of assays of this type should make it possible to discover numerous small molecule cytokine modulators with significant utility in the clinic.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abramovich C, Yakobson B, Chebath J and Revel M . 1997 EMBO J 16: 260–266
Ahmed T, Wuest D and Ciavarella D . 1992 J Clin Apheresis 7: 129–131
Baselga J, Norton L, Albanell J, Kim YM and Mendelsohn J . 1998 Cancer Res 58: 2825–2831
Braunwaler AF, Yarwood DR, Hall T, Missbach M, Lipson KE and Sills MA . 1996 Anal Biochem 234: 23–26
Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell Jr JE . 1999 Cell 98: 295–303
Broudy VC, Lin NL, Buhring HJ, Komatsu N and Kavanagh TJ . 1998 Blood 91: 898–906
Catlett-Falcone R, Dalton WS and Jove R . 1999 Curr Opin Oncol 11: 490–496
Chen D, Ma H, Hong H, Koh SS, Huang SM, Schurter BT, Aswad DW and Stallcup MR . 1999 Science 284: 2174–2177
Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P and Shuai K . 1997 Science 278: 1803–1805
Damjanovich S, Bene L, Matko J, Alileche A, Goldman CK, Sharrow S and Waldmann TA . 1997 Proc Natl Acad Sci USA 94: 13134–13139
Darnell Jr JE, Kerr IM and Stark GR . 1994 Science 264: 1415–1421
Decker T, Kovarik P and Meinke A . 1997 J Interferon Cytokine Res 17: 121–134
Durbin JE, Hackenmiller R, Simon MC and Levy DE . 1996 Cell 84: 443–450
Eschbach JW, Egrie JC, Downing MR, Browne JK and Adamson JW . 1987 N Engl J Med 316: 73–78
Fry DW, Kraker AJ, McMichael A, Ambroso LA, Nelson JM, Leopold WR, Connors RW and Bridges AJ . 1994 Science 265: 1093–1095
Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV and Wells JA . 1992 Science 256: 1677–1680
Giralt S, Kantarjian H and Talpaz M . 1995 Semin Hematol 32: 152–158
Goodman PA, Niehoff LB and Uckun FM . 1998 J Biol Chem 273: 17742–17748
Greenlund AC, Morales MO, Viviano BL, Yan H, Krolewski J and Schreiber RD . 1995 Immunity 2: 677–687
Haspel RL and Darnell Jr JE . 1999 Proc Natl Acad Sci USA 96: 10188–10193
Hoofnagle JH . 1990 J Hepatol 11, Suppl 1: S100–S107
Horvath CM, Wen Z and Darnell Jr JE . 1995 Genes Dev 9: 984–994
Ihle JN . 1995 Adv Immunol 60: 1–35
Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvennoinen O . 1994 Trends Biochem Sci 19: 222–227
Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ and Schreiber RD . 1998 Proc Natl Acad Sci USA 95: 7556–7561
Kaplan MH, Schindler U, Smiley ST and Grusby MJ . 1996a Immunity 4: 313–319
Kaplan MH, Sun YL, Hoey T and Grusby MJ . 1996b Nature 382: 174–177
Klingmuller U, Lorenz U, Cantley LC, Neel BG and Lodish HF . 1995 Cell 80: 729–738
Kolb A, Burke J and Mathis G . 1997 High Throughput Screening The Discovery of Bioactive Molecules Devlin J ed Marcel Dekker New York pp 345–360
Lamb P, Tapley P and Rosen J . 1998 Drug Discovery Today 3: 122–130
Lamb P, Seidel HM, Haslam J, Milocco L, Kessler LV, Stein RB and Rosen J . 1995 Nucleic Acids Res 23: 3283–3289
Lindsay KL . 1999 J Hepatol, Suppl 1 232–236
Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD and Shuai K . 1998 Proc Natl Acad Sci USA 95: 10626–10631
Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M and Schreiber RD . 1996 Cell 84: 431–442
Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A and Roifman CM . 1996 Nature 379: 645–648
Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K, Widmer MB and Blosch CM . 1997 N Engl J Med 337: 141–147
Moriggl R, Sexl V, Piekorz R, Topham D and Ihle JN . 1999 Immunity 11: 225–230
Nasir MS and Jolley ME . 1999 Comb Chem High Throughput Screen 2: 177–190
Nemunaitis J, Singer JW, Buckner CD, Hill R, Storb R, Thomas ED and Appelbaum FR . 1998 Blood 72: 834–836
Panitch HS . 1995 Mult Scler 1Suppl 1: S17–S21
Quelle FW, Thierfelder W, Witthuhn BA, Tang B, Cohen S and Ihle JN . 1995 J Biol Chem 270: 20775–20780
Racker E . 1991 Methods Enzymol 200: 107–111
Remy I, Wilson IA and Michnick SW . 1999 Science 283: 990–993
Schneider H, Chaovapong W, Matthews D, Karkaria C, Cass RT, Zahn H, Boyle M, Lorenzini T, Elliot SG and Geibel L . 1997 Blood 89: 473–482
Seidel HM, Milocco LH, Lamb P, Darnell Jr JE, Stein RB and Rosen J . 1995 Proc Natl Acad Sci USA 92: 3041–3045
Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DA, Doherty PC, Grosveld G, Paul WE and Ihle JN . 1996 Nature 380: 630–633
Shuai K, Horvath CM, Huang LH, Qureshi SA, Cowburn D and Darnell Jr JE . 1994 Cell 76: 821–828
Silverman L, Campbell R and Broach JR . 1998 Curr Opin Chem Biol 2: 397–403
Sittampalam GS, Kahl SD and Janzen WP . 1997 Curr Opin Chem Biol 1: 384–391
Spielberger RT and Golomb HM . 1992 Leukemia 4: 142–146
Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA and Hilton DJ . 1997 Nature 387: 917–921
Stockwell BR, Haggarty SJ and Schreiber SL . 1999 Chem Biol 6: 71–83
Stone WJ, Graber SE, Krantz SB, Dessypris EN, O'Neil VL, Olsen NJ and Pincus TP . 1988 Am J Med Sci 296: 171–179
Stryer L . 1978 Annu Rev Biochem 47: 819–846
Sudbeck EA, Liu XP, Narla RK, Mahajan S, Ghosh S, Mao C and Uckun FM . 1999 Clin Cancer Res 5: 1569–1582
Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T and Akira S . 1996 Nature 380: 627–630
Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF and Rutgeerts PJ . 1997 N Engl J Med 337: 1029–1035
Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DA, Doherty PC, Grosveld GC and Ihle JN . 1996 Nature 382: 171–174
Tian S-S, Lamb P, King AG, Miller SG, Kessler L, Luengo JI, Averill L, Johnson RK, Gleason JG, Pelus LM, Dillon SB and Rosen J . 1998 Science 281: 257–259
Trieu VN, Liu R, Liu XP and Uckun FM . 2000 Biochem Biophys Res Commun 267: 22–25
Tsui HW, Siminovitch KA, de Souza L and Tsui FW . 1993 Nat Genet 4: 124–129
Wagner BJ, Hayes TE, Hoban CJ and Cochran BH . 1990 EMBO J 9: 4477–4484
Wang LH, Kirken RA, Erwin RA, Yu CR and Farrar WL . 1999 J Immunol 162: 3897–3904
Welte K, Bonilla MA, Gillio AP, Boone TC, Potter GK, Gabrilove JL, Moore MA, O'Reilly RJ and Souza LM . 1987 J Exp Med 165: 941–948
Welte K, Gabrilove J, Bronchud MH, Platzer E and Morstyn G . 1996 Blood 88: 1907–1922
Whitty A and Borysenko CW . 1999 Chem Biol 6: R107–R118
Wu P, Brasseur M and Schindler U . 1997 Anal Biochem 249: 29–36
Acknowledgements
We thank Peter Syka and Jennifer Haslam for assistance with the STAT biochemical assay and Mechele Cook for help with the manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Seidel, H., Lamb, P. & Rosen, J. Pharmaceutical intervention in the JAK/STAT signaling pathway. Oncogene 19, 2645–2656 (2000). https://doi.org/10.1038/sj.onc.1203550
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203550
Keywords
This article is cited by
-
Calycosin-7-O-β-d-glucoside attenuates myocardial ischemia–reperfusion injury by activating JAK2/STAT3 signaling pathway via the regulation of IL-10 secretion in mice
Molecular and Cellular Biochemistry (2020)
-
Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts
Drugs & Aging (2017)
-
St. John’s wort extract and hyperforin protect rat and human pancreatic islets against cytokine toxicity
Acta Diabetologica (2014)
-
Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer
British Journal of Cancer (2012)
-
Expression of Stat3 in Feline Mammary Gland Tumours and its Relation to Histological Grade
Veterinary Research Communications (2006)